Dow Up 0.26% Nasdaq Down 1.07%

Gilead Sciences Inc. (GILD)

-NasdaqGS
100.99 Down 2.67(2.58%) 4:15PM EDT
|After Hours : 100.63 Down 0.36 (0.36%) 7:59PM EDT
Prev Close:103.66
Open:101.78
Bid:100.33 x 100
Ask:100.81 x 100
1y Target Est:112.43
Beta:0.95
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:99.33 - 102.10
52wk Range:58.81 - 110.64
Volume:18,163,898
Avg Vol (3m):12,902,500
Market Cap:152.66B
P/E (ttm):37.40
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Headlines

» More Headlines for GILD

Comparison

Symbol% ChgMkt Cap
GILDDown 2.58%152.66B
GSKDown 0.17%112.85B
PFEUp 1.66%189.72B
RHHBYUp 0.71%251.14B

Key Statistics

Forward P/E (1 yr):10.79
P/S (ttm):8.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.01
Quarterly EPS Est (Sep-14) :1.90
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback